Heidelberg, Germany · Founded 2015 · Privately Held (backing)
Developer of antitussive medication designed to address both the neurological and psychological aspects of behavioral and psychological symptoms. Exciva is based in Heidelberg, Germany and was founded in 2015. Its last reported valuation was $16.4 million in Oct 2021. It has raised $70.1 million.
Last reported valuation
$16.4M
Oct 2026
Priced at
—
Total raised
$70.1M
Last round
—
Cap table — not yet on record
Exciva's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Exciva with a free account
·Watch Exciva: the Monday email on marks, rounds and moves
